Publication | Closed Access

A comparison of weekly paclitaxel and cetuximab with the EXTREME regimen in the treatment of recurrent/metastatic squamous cell head and neck carcinoma

Extreme RegimenMedicinePathologyWeekly PaclitaxelHead And Neck CancerNeck CarcinomaCancer TreatmentNeck OncologyOncologyRadiation Oncology